Physician profile
Tamara Kemp
NPI 1164650214
$15,853.31
in general payments reported to CMS, 2019-2025
16 companies · $5,146 in 2025
The $5,146 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,475 · 2021: $407 · 2022: $361 · 2023: $3,138 · 2024: $4,328 · 2025: $5,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,341 · Travel and Lodging: $5,070 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,340.94 |
| Travel and Lodging | $5,069.98 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $9,115.38 | 2020-2025 | |
| Rti Surgical, INC | $1,833.16 | 2023-2025 | |
| Mentor Worldwide LLC | $1,687.93 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medical Device Business Services, INC. | $633.85 | 2024 | |
| Abbvie INC. | $480.64 | 2023-2025 | |
| Somavac Medical Solutions, INC. | $400.32 | 2025 | Somavac 100 Sustained Vacuum System |
| Lifenet Health | $302.33 | 2024-2025 | Theragenesis Wound Matrix |
| Polynovo North America LLC | $301.03 | 2023-2025 | Novosorb Btm |
| Motiva USA, LLC | $247.34 | 2025 | |
| Access Pro Medical, LLC | $164.63 | 2025 | Matriderm |
| Davol INC. | $161.08 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip |
| Merck Sharp & Dohme LLC | $123.88 | 2023 | Keytruda |
| Avita Medical Americas, LLC | $111.93 | 2023-2024 | Recell |
| Sanara Medtech INC. | $110.04 | 2025 | Celleraterx |
| Mimedx Group, INC. | $108.23 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $71.54 | 2023 | Durasorb Monofilament Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$112,302.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Kemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.